US FDA declines to approve Applied Therapeutics' genetic disease drug
Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...
MedPage Today1h
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...
RFK's Policies Sound Populist, But Actually Indulge Elite Fantasies | Opinion
President-elect Donald Trump is stacking the Department of Health and Human Services with people who are poised to favor the ...
FDA probes blood cancer risk from bluebird's gene therapy, weighs regulatory action
The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...
Soup Recall Update as FDA Sets Highest Risk Level
A soup mix recall issued this month has been updated by the U.S. Food and Drug Administration ( FDA) as a Class I risk, the ...
Seafood Recall Update As FDA Sets Risk Level
The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...
Meet the medical contrarians picked to lead health agencies under Trump and Kennedy
Donald Trump's health team picks includes outspoken critics of the medical establishment and COVID-19 health measures ...
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
Hoping for Allies Among Trump’s Health Picks, Pharma Faces Hostility
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for ...
Applied Therapeutics Receives FDA Complete Response Letter for Govorestat New Drug Application
Applied Therapeutics said it has received a complete response letter from the Food and Drug Administration related to its new drug application for govorestat due to deficiencies in the clinical ...
The American Journal of Managed Care1h
US ADHD Stimulant Shortage Highlights Growing Challenges in Adult Treatment
While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear ...
Verywell Health on MSN4h
How Trump’s Picks for Top Health Agencies Could Change U.S. Health Care
Trump selected three medical doctors for key positions in his administration's health agencies. What to know about their ...